Doctors develop 'safer' prenatal diagnostic test
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.DOCTORS at a London hospital are developing a new prenatal diagnostic test which may be safer than existing techniques, and can be carried out earlier in pregnancy.
The test, known as coelocentesis, does not involve puncturing any of the membranes surrounding the foetus or the placenta, nor does it damage the blood vessels supplying it with oxygen and nutrients. Instead, a needle guided by ultrasound is introduced through the woman's vagina and fluid removed from the coelomic cavity, which surrounds the foetus in the first 12 weeks of pregnancy.
A preliminary study of 100 women at King's College Hospital achieved a 70 per cent success rate in obtaining a sample, with better results at 6 to 10 weeks than after 10 weeks, according to a report in The Lancet. The test is carried out under general anaesthetic. The women who agreed to take part in the trial were undergoing abortions for psychological reasons.
Conventional prenatal diagnostic testing includes amniocentesis, in which fluid from around the foetus is removed, and chorionic villus sampling (CVS) of the placenta. But amniocentesis is not usually carried out until 15-18 weeks, when a woman can feel foetal movement, and CVS, after 9.5 weeks, has been linked with limb abnormalities. Early amniocentesis is increasingly available, but has not been properly assessed and there are risks to foetal lung development.
The researchers, led by Professor Stuart Campbell, say that the risks of coelocentesis in women who are continuing their pregnancy have yet to be determined, but it has potential as an early prenatal test and may be safer than existing methods.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments